TG THERAPEUTICS INC
TGTX·88322Q108·US·Common Stock·Healthcare - Biotechnology-13D/G
TGTX (TG THERAPEUTICS INC) is held by 167 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($739.2M), STATE STREET CORP ($287.3M), VANGUARD PORTFOLIO MANAGEMENT LLC ($274.9M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 96 funds bought TGTX.
167
Holders
Avg rating(34 Elite)
$3.1B
Total Value
55% (184)
Fund Consensus
96 buying - 80 selling
Who's Trading
InsiderEYEchelard YannSell $163KNov 24, 2025
InsiderLSLonial SagarSell $672KSep 11, 2025
InsiderEYEchelard YannSell $369KJun 13, 2025
13F: Insider & Congress:
Showing 1-20 of 184
1 / 10
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer